106.47
price up icon0.60%   0.63
after-market After Hours: 106.47
loading
Boston Scientific Corp stock is traded at $106.47, with a volume of 6.35M. It is up +0.60% in the last 24 hours and down -0.06% over the past month. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$105.84
Open:
$106.68
24h Volume:
6.35M
Relative Volume:
0.88
Market Cap:
$157.52B
Revenue:
$18.49B
Net Income/Loss:
$2.51B
P/E Ratio:
63.38
EPS:
1.68
Net Cash Flow:
$2.72B
1W Performance:
+3.21%
1M Performance:
-0.06%
6M Performance:
+3.66%
1Y Performance:
+40.85%
1-Day Range:
Value
$106.10
$107.25
1-Week Range:
Value
$104.69
$108.53
52-Week Range:
Value
$71.88
$108.53

Boston Scientific Corp Stock (BSX) Company Profile

Name
Name
Boston Scientific Corp
Name
Phone
508-683-4000
Name
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
Employee
53,000
Name
Twitter
@bostonsci
Name
Next Earnings Date
2025-07-23
Name
Latest SEC Filings
Name
BSX's Discussions on Twitter

Compare BSX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
BSX
Boston Scientific Corp
106.47 156.58B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
ABT
Abbott Laboratories
128.01 219.83B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
SYK
Stryker Corp
400.57 153.13B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.44 117.84B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
80.47 46.04B 5.69B 4.15B 623.10M 6.95

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-16-25 Initiated Leerink Partners Outperform
Apr-16-25 Upgrade Needham Hold → Buy
Jan-10-25 Upgrade Deutsche Bank Hold → Buy
Oct-18-24 Downgrade Needham Buy → Hold
May-30-24 Initiated Goldman Buy
Feb-01-24 Upgrade Mizuho Neutral → Buy
Jul-19-23 Initiated Robert W. Baird Outperform
Jun-30-23 Initiated CL King Buy
May-30-23 Resumed Morgan Stanley Overweight
Mar-29-23 Initiated UBS Buy
Dec-22-22 Initiated Mizuho Neutral
Dec-20-22 Resumed Citigroup Buy
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-06-22 Initiated Wolfe Research Outperform
May-27-22 Upgrade Needham Hold → Buy
Apr-13-22 Resumed Truist Buy
Mar-02-22 Resumed BofA Securities Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
May-26-21 Downgrade Needham Buy → Hold
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Overweight
Sep-17-20 Initiated Truist Buy
Sep-11-20 Initiated Wolfe Research Peer Perform
Apr-22-20 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-01-20 Upgrade Goldman Neutral → Buy
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Buy
Dec-30-19 Reiterated Cowen Outperform
Dec-19-19 Downgrade Needham Strong Buy → Buy
Sep-05-19 Resumed JP Morgan Overweight
Sep-03-19 Resumed Barclays Overweight
May-13-19 Upgrade Evercore ISI In-line → Outperform
Nov-28-18 Initiated UBS Buy
Oct-16-18 Initiated Barclays Overweight
Oct-02-18 Reiterated Morgan Stanley Overweight
Sep-07-18 Reiterated Needham Strong Buy
Sep-04-18 Upgrade Jefferies Hold → Buy
Jul-06-18 Reiterated Needham Strong Buy
Jun-27-18 Initiated Bernstein Outperform
Apr-26-18 Reiterated Needham Strong Buy
View All

Boston Scientific Corp Stock (BSX) Latest News

pulisher
09:43 AM

Boston Scientific Corporation Reversal Rally May Surprise BearsOversold Bounce Stock Play Ideas Gain Attention - metal.it

09:43 AM
pulisher
04:38 AM

Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott - GlobeNewswire Inc.

04:38 AM
pulisher
Jul 28, 2025

Boston Scientific’s SWOT analysis: innovation drives stock amid challenges - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Boston Scientific CorporationSuperior returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

RBC Capital Raises PT on Boston Scientific Corporation (BSX) to $125 From $120 - Insider Monkey

Jul 28, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Boston Scientific CorporationIdentify undervalued stocks poised to rally - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Boston Scientific Corporation compare to its industry peersMaximize portfolio growth with professional advice - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Boston Scientific Corporation (BSX) Is One Of The Most Reliable Companies, Says Jim Cramer - Insider Monkey

Jul 26, 2025
pulisher
Jul 25, 2025

TD Cowen Reiterates a Buy Rating on Boston Scientific Corporation (BSX) - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

10 Best Strong Buy Healthcare Stocks to Buy Now - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

FSHPU seeks shareholder OK to cut extension fee to $60k/month, preserve GFT merger | BSX SEC FilingForm 144 - Stock Titan

Jul 25, 2025
pulisher
Jul 25, 2025

Boston Scientific's (NYSE:BSX) investors will be pleased with their solid 173% return over the last five years - Yahoo.co

Jul 25, 2025
pulisher
Jul 25, 2025

Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Boston Scientific Reports Strong Q2 2025 Results - The Globe and Mail

Jul 25, 2025
pulisher
Jul 24, 2025

Boston Scientific (BSX) Target Price Raised by Raymond James | B - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific (BSX) Price Target Raised by Oppenheimer | BSX Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific stock price target raised to $125 from $120 at RBC Capital - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is Boston Scientific Corporation stock overhyped or has real potentialSuperior stock growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Sci posts 117% U.S. PFA growth, halves tariff impact - BioWorld MedTech

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific stock price target raised to $130 from $124 at Bernstein - Investing.com Canada

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific (BSX) Price Target Increased by RBC Capital | - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

BSX: Boston Scientific Sees Price Target Raised by Truist Securi - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Stocks making big moves yesterday: Power Integrations, Booz Allen Hamilton, Wendy's, SentinelOne, and Boston Scientific - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific (BSX) Price Target Raised by Baird Analyst | B - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific stock price target raised to $140 from $130 at Mizuho - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific (BSX) Price Target Increased by Baird | BSX Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific (BSX) Price Target Raised to $118 by Oppenheimer | BSX Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

UBS Boosts Price Target for Boston Scientific (BSX) Amid Strong Performance | BSX Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific stock price target raised to $135 by UBS on strong product cycle - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Company News for Jul 24, 2025 - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific stock price target raised to $124 by Wells Fargo on PFA growth - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific (BSX) Sees Price Target Boost from Barclays | - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Boston Scientific Corp (BSX) Q2 2025 Earnings Call Highlights: Surpassing Expectations with ... By GuruFocus - Investing.com Canada

Jul 24, 2025
pulisher
Jul 23, 2025

Boston Scientific: Q2 Earnings Snapshot - Greenwich Time

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific’s Strong Financial Performance and Positive Outlook Earns Buy Rating - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Should You Buy or Sell Boston Scientific Stock Ahead of Its Upcoming Earnings? - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

Why Boston Scientific (BSX) Stock Is Up Today - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific lifts 2025 outlook following 29% Q2 cardiovascular profit rise - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific stock price target raised to $120 by BofA Securities - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific (BSX) Price Target Increased by BofA Analyst | - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific Presses Its Advantage in Pulsed Field Ablation - Morningstar

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific halves expected tariff hit - MedTech Dive

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific Lifts Outlook On Cardiovascular Revenue Growth - Finimize

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific lifts annual profit forecast, sees smaller tariff impact - Reuters

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific lifts annual profit forecast, sees smaller tariff impact By Reuters - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific stock hits all-time high at 107.76 USD By Investing.com - Investing.com Nigeria

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific stock hits all-time high at 107.76 USD - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Earnings call transcript: Boston Scientific Q2 2025 beats expectations, stock rises - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Boston Scientific lifts annual profit view on steady heart devices demand - Yahoo.co

Jul 23, 2025

Boston Scientific Corp Stock (BSX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices SYK
$400.57
price down icon 0.03%
medical_devices MDT
$92.44
price up icon 0.51%
medical_devices ABT
$128.01
price up icon 1.31%
medical_devices EW
$80.47
price up icon 2.52%
$77.72
price down icon 0.03%
Cap:     |  Volume (24h):